Human Genome Sciences, Inc.
Human Genome Sciences Reports Increasing Momentum toward Commercialization and Announces 2010 Goals at JPMorgan Healthcare Conference
Published in Clinical Trials Week, January 25th, 2010
"2010 will be another pivotal year for HGS," said Mr. Watkins. "In 2009, we and our partners successfully completed Phase 3 development of BENLYSTA for systemic lupus and ZALBIN for chronic hepatitis C. In the fourth quarter of 2009, we submitted a Biologics...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2010-01-25)
More Articles from Clinical Trials Week
- American Association for Cancer Research
Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug - Absorption Systems
Study Shows the Unique Power of Absorption Systems' CellPort Technologies(TM) - Genta Incorporated
Two New Studies Show Gallium-Containing Compounds Significantly Increase Bone Strength in Standard Models of Osteoporosis - Medifocus, Inc.
Medifocus, Inc. Announces Positive Clinical Results of Its Breast Cancer Treatment Studies Published in Annals of Surgical Oncology: Planning to Begin Phase III In Early 2010 - NewsRx
NewsRx Publishes Encyclopedia of Breast Cancer, 2009: an encyK Resource for Patients & Professionals - Onset Medical Corporation
Onset Medical Announces New Website www.onsetmedical.com - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
